Patent 12129499 was granted and assigned to Seismic Therapeutic, Inc on October, 2024 by the United States Patent and Trademark Office.
Embodiments provided herein, provide for polypeptides and molecules comprising a polypeptide having protease activity and a variant Fc molecule, pharmaceutical compositions comprising the same, and methods that can be used to treat disorders, such as IgG mediated disorders.